Shanghai North Carolina passed the "Little Giant" annual acceptance
Release time:
2020-08-14
Shanghai North Carolina Passed "Little Giant" Annual Acceptance
News Recently, Shanghai North Carolina Pharmaceutical Technology Co., Ltd., a new member of Jianfeng Pharmaceutical Co., Ltd., successfully passed the annual acceptance of Shanghai Science and Technology "Little Giant" Cultivation Enterprise.
In order to promote the independent innovation of enterprises, improve the core competitiveness of enterprises, enhance the competitive advantages of enterprises in domestic and foreign industries, and accelerate the construction of scientific and technological innovation, Shanghai North Carolina 2016 declared the Shanghai "Science and Technology Innovation Action Plan" science and technology "Little Giant" cultivation project and was approved, becoming a member of Shanghai's 87 "Little Giant" cultivation enterprises in that year, the project execution period is 2 years.
During the period of the Little Giant Cultivation Project, North Carolina completed the re-identification of Shanghai High-tech Enterprises and the identification of Songjiang District Enterprise Technology Center. Songjiang District Enterprise Technology Center was evaluated as excellent, passed the certification of Shanghai Academician Expert Workstation, passed the acceptance of Shanghai Patent Work Pilot Enterprises, and obtained a total of 4 invention patents authorized and 12 invention patents applied, registered trademarks 2 items, formulated enterprise standards 4 items, product testing reports 22 items, 2017 Songjiang District Industry-University-Research Innovation Project was approved and the project target was completed. Tinib drugs and their intermediates of
non-small cell lung cancer (NSCLC ) are the dominant varieties in North Carolina. In order to improve the existing tinib product line and consolidate the economic benefits and market share of this kind of products, North Carolina has carried out research and development on the latest generation of precision medicine special effect drugs such as cabozantinib (Cabozantinib) , ceritinib (Ceritinib ) and other kinds of API intermediates for tinib star varieties which are hot spots in the clinical research and development of generic drugs, also focus on the development of palbociclib (Palbociclib ) and gefitinib and other varieties of intermediate production process industrialization pilot and scale-up, and in-depth quality research and factory industrialization practice. In addition, North Carolina has also vigorously expanded the industrialization of the anti-diabetic drug pioglitazone, as well as the development of other products such as the endogenous active substance Paricalcitol, and carried out product layout for future development.
During the cultivation project period, North Carolina completed various tasks such as the optimization and construction of the innovation environment, the construction of the research and development team, and the research and development of scientific research projects, and carried out the upgrading and transformation of the research and development laboratory and pilot test platform, EIA filing and supporting environmental protection treatment facilities. 3# In mid-June, the Shanghai Municipal Science and Technology Commission launched the acceptance and evaluation of Shanghai's "Little Giant" enterprises. 12 enterprises recommended by the Songjiang District Science and Technology Commission participated in the defense. Kang Litao, general manager of Shanghai North Carolina, Li Qian, deputy general manager, and heads of R & D, finance and other departments participated in the on-site defense and successfully passed the defense acceptance. (Yang Shiqiong)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page